Jakub Tomala

963 total citations
26 papers, 712 citations indexed

About

Jakub Tomala is a scholar working on Immunology, Oncology and Microbiology. According to data from OpenAlex, Jakub Tomala has authored 26 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 10 papers in Oncology and 5 papers in Microbiology. Recurrent topics in Jakub Tomala's work include Immune Cell Function and Interaction (11 papers), T-cell and B-cell Immunology (10 papers) and Immunotherapy and Immune Responses (8 papers). Jakub Tomala is often cited by papers focused on Immune Cell Function and Interaction (11 papers), T-cell and B-cell Immunology (10 papers) and Immunotherapy and Immune Responses (8 papers). Jakub Tomala collaborates with scholars based in Czechia, United States and Belarus. Jakub Tomala's co-authors include Marek Kovář, Blanka Řı́hová, Jamie B. Spangler, K. Christopher García, Marion Pepper, Vincent C. Luca, Aaron M. Ring, Shen Dong, Tomáš Mrkvan and Kevin M. Jude and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Immunity and The Journal of Immunology.

In The Last Decade

Jakub Tomala

26 papers receiving 706 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jakub Tomala Czechia 15 386 208 153 116 106 26 712
Ying Waeckerle‐Men Switzerland 19 692 1.8× 215 1.0× 371 2.4× 121 1.0× 60 0.6× 30 1.1k
Jonna Alanko Finland 11 146 0.4× 148 0.7× 432 2.8× 51 0.4× 22 0.2× 16 957
Martino Ambrosini Netherlands 19 679 1.8× 123 0.6× 644 4.2× 90 0.8× 50 0.5× 26 1.0k
Lisa H. Tostanoski United States 19 774 2.0× 168 0.8× 576 3.8× 274 2.4× 107 1.0× 33 1.4k
Lianne Vriend Netherlands 15 284 0.7× 230 1.1× 404 2.6× 214 1.8× 55 0.5× 18 928
Shuang Qing China 9 248 0.6× 79 0.4× 343 2.2× 294 2.5× 90 0.8× 10 705
Dodie Pouniotis Australia 21 764 2.0× 198 1.0× 707 4.6× 69 0.6× 56 0.5× 41 1.4k
Michael Look United States 11 426 1.1× 206 1.0× 311 2.0× 378 3.3× 230 2.2× 13 959
Yale Yue China 14 393 1.0× 148 0.7× 640 4.2× 760 6.6× 140 1.3× 19 1.4k
Maya Holay United States 14 334 0.9× 90 0.4× 490 3.2× 580 5.0× 256 2.4× 16 1.1k

Countries citing papers authored by Jakub Tomala

Since Specialization
Citations

This map shows the geographic impact of Jakub Tomala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jakub Tomala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jakub Tomala more than expected).

Fields of papers citing papers by Jakub Tomala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jakub Tomala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jakub Tomala. The network helps show where Jakub Tomala may publish in the future.

Co-authorship network of co-authors of Jakub Tomala

This figure shows the co-authorship network connecting the top 25 collaborators of Jakub Tomala. A scholar is included among the top collaborators of Jakub Tomala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jakub Tomala. Jakub Tomala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seddu, Kumba, Kaitavjeet Chowdhary, Jakub Tomala, et al.. (2025). Dynamics and variegation in the Treg response to Interleukin-2. Proceedings of the National Academy of Sciences. 122(47). e2518991122–e2518991122. 1 indexed citations
2.
Tomala, Jakub, et al.. (2023). Combined in vitro and cell‐based selection display method producing specific binders against IL ‐9 receptor in high yields. FEBS Journal. 290(11). 2993–3005. 2 indexed citations
3.
Tomala, Jakub, et al.. (2022). Pertussis toxin suppresses dendritic cell-mediated delivery of B. pertussis into lung-draining lymph nodes. PLoS Pathogens. 18(6). e1010577–e1010577. 8 indexed citations
4.
Tomala, Jakub, Milada Šírová, Guy de Martynoff, et al.. (2022). SOT101 induces NK cell cytotoxicity and potentiates antibody-dependent cell cytotoxicity and anti-tumor activity. Frontiers in Immunology. 13. 989895–989895. 8 indexed citations
6.
Sivák, Ladislav, Vladimír Šubr, Milada Šírová, et al.. (2021). Polymer-ritonavir derivate nanomedicine with pH-sensitive activation possesses potent anti-tumor activity in vivo via inhibition of proteasome and STAT3 signaling. Journal of Controlled Release. 332. 563–580. 12 indexed citations
8.
Spangler, Jamie B., Eleonora Trotta, Jakub Tomala, et al.. (2018). Engineering a Single-Agent Cytokine/Antibody Fusion That Selectively Expands Regulatory T Cells for Autoimmune Disease Therapy. The Journal of Immunology. 201(7). 2094–2106. 53 indexed citations
9.
Šírová, Milada, J. Strohalm, Petr Chytil, et al.. (2016). The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and docetaxel. Journal of Controlled Release. 246. 1–11. 24 indexed citations
10.
Sivák, Ladislav, Vladimír Šubr, Jakub Tomala, et al.. (2016). Overcoming multidrug resistance via simultaneous delivery of cytostatic drug and P-glycoprotein inhibitor to cancer cells by HPMA copolymer conjugate. Biomaterials. 115. 65–80. 44 indexed citations
11.
Šírová, Milada, P Roßmann, Robert Pola, et al.. (2015). The structure-dependent toxicity, pharmacokinetics and anti-tumour activity of HPMA copolymer conjugates in the treatment of solid tumours and leukaemia. Journal of Controlled Release. 223. 1–10. 35 indexed citations
12.
Spangler, Jamie B., Jakub Tomala, Vincent C. Luca, et al.. (2015). Antibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation through Distinct Conformational Mechanisms. Immunity. 42(5). 815–825. 166 indexed citations
13.
Tomala, Jakub & Marek Kovář. (2015). IL-2/anti-IL-2 mAb immunocomplexes: A renascence of IL-2 in cancer immunotherapy?. OncoImmunology. 5(3). e1102829–e1102829. 21 indexed citations
14.
Tomala, Jakub, Vladimír Šubr, J. Strohalm, et al.. (2015). Novel IL-2-Poly(HPMA)Nanoconjugate Based Immunotherapy. Journal of Biomedical Nanotechnology. 11(9). 1662–1673. 13 indexed citations
15.
Mašín, Jiří, Radovan Fišer, Ondřej Černý, et al.. (2015). Pore‐formation by adenylate cyclase toxoid activates dendritic cells to prime CD8+ and CD4+ T cells. Immunology and Cell Biology. 94(4). 322–333. 18 indexed citations
16.
Adkins, Irena, Jana Kamanová, Jakub Tomala, et al.. (2014). Bordetella Adenylate Cyclase Toxin Differentially Modulates Toll-Like Receptor-Stimulated Activation, Migration and T Cell Stimulatory Capacity of Dendritic Cells. PLoS ONE. 9(8). e104064–e104064. 24 indexed citations
17.
Tomala, Jakub, et al.. (2014). Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimera. Immunology Letters. 159(1-2). 1–10. 25 indexed citations
18.
Řı́hová, Blanka, Tomáš Etrych, Milada Šírová, et al.. (2011). Synergistic effect of EMF–BEMER-type pulsed weak electromagnetic field and HPMA-bound doxorubicin on mouse EL4 T-cell lymphoma. Journal of drug targeting. 19(10). 890–899. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026